247 related articles for article (PubMed ID: 22664150)
41. BNIP3 Is Involved in Muscle Fiber Atrophy in Late-Onset Pompe Disease Patients.
Carrasco-Rozas A; Fernández-Simón E; Suárez-Calvet X; Piñol-Jurado P; Alonso-Pérez J; de Luna N; Schoser B; Meinke P; Domínguez-González C; Hernández-Laín A; Paradas C; Rivas E; Illa I; Olivé M; Gallardo E; Díaz-Manera J
Am J Pathol; 2022 Aug; 192(8):1151-1166. PubMed ID: 35605642
[TBL] [Abstract][Full Text] [Related]
42. A study on the safety and efficacy of reveglucosidase alfa in patients with late-onset Pompe disease.
Byrne BJ; Geberhiwot T; Barshop BA; Barohn R; Hughes D; Bratkovic D; Desnuelle C; Laforet P; Mengel E; Roberts M; Haroldsen P; Reilley K; Jayaram K; Yang K; Walsh L;
Orphanet J Rare Dis; 2017 Aug; 12(1):144. PubMed ID: 28838325
[TBL] [Abstract][Full Text] [Related]
43. Quantitative assessment of lingual strength in late-onset Pompe disease.
Jones HN; Crisp KD; Asrani P; Sloane R; Kishnani PS
Muscle Nerve; 2015 May; 51(5):731-5. PubMed ID: 25399907
[TBL] [Abstract][Full Text] [Related]
44. Treatment Dilemma in Children with Late-Onset Pompe Disease.
Faraguna MC; Crescitelli V; Fornari A; Barzaghi S; Savasta S; Foiadelli T; Veraldi D; Paoletti M; Pichiecchio A; Gasperini S
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833288
[TBL] [Abstract][Full Text] [Related]
45. Multisystem late onset Pompe disease (LOPD): an update on clinical aspects.
Toscano A; Rodolico C; Musumeci O
Ann Transl Med; 2019 Jul; 7(13):284. PubMed ID: 31392196
[TBL] [Abstract][Full Text] [Related]
46. Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles.
Nuñez-Peralta C; Alonso-Pérez J; Llauger J; Segovia S; Montesinos P; Belmonte I; Pedrosa I; Montiel E; Alonso-Jiménez A; Sánchez-González J; Martínez-Noguera A; Illa I; Díaz-Manera J
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):1032-1046. PubMed ID: 32129012
[TBL] [Abstract][Full Text] [Related]
47. Clinical and histologic ocular findings in pompe disease.
Yanovitch TL; Banugaria SG; Proia AD; Kishnani PS
J Pediatr Ophthalmol Strabismus; 2010; 47(1):34-40. PubMed ID: 20128552
[TBL] [Abstract][Full Text] [Related]
48. Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients.
Sheng B; Chu YP; Wong WT; Yau EKC; Chen SPL; Luk WH
BMC Res Notes; 2017 Jul; 10(1):351. PubMed ID: 28754168
[TBL] [Abstract][Full Text] [Related]
49. Characterization of gait in late onset Pompe disease.
McIntosh PT; Case LE; Chan JM; Austin SL; Kishnani P
Mol Genet Metab; 2015 Nov; 116(3):152-6. PubMed ID: 26372341
[TBL] [Abstract][Full Text] [Related]
50. Nosology of lysosomal glycogen storage diseases without in vitro acid maltase deficiency. Delineation of a neonatal form.
Verloes A; Massin M; Lombet J; Grattagliano B; Soyeur D; Rigo J; Koulischer L; Van Hoof F
Am J Med Genet; 1997 Oct; 72(2):135-42. PubMed ID: 9382133
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic tools in late onset Pompe disease (LOPD).
Musumeci O; Toscano A
Ann Transl Med; 2019 Jul; 7(13):286. PubMed ID: 31392198
[TBL] [Abstract][Full Text] [Related]
52. A challenging etiology of myopathy: The late-onset Pompe disease.
Yüce İnel T; Köken Avşar A; Teke Kısa P; Özer E; Sarı İ
Eur J Rheumatol; 2023 Jan; 10(1):26-28. PubMed ID: 35943460
[TBL] [Abstract][Full Text] [Related]
53. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
[TBL] [Abstract][Full Text] [Related]
54. Are there common walking gait characteristics in patients diagnosed with late-onset Pompe disease?
Starbuck C; Reay J; Silk E; Roberts M; Hendriksz C; Jones R
Hum Mov Sci; 2021 Jun; 77():102777. PubMed ID: 33730657
[TBL] [Abstract][Full Text] [Related]
55. Skeletal muscle magnetic resonance imaging in Pompe disease.
Díaz-Manera J; Walter G; Straub V
Muscle Nerve; 2021 May; 63(5):640-650. PubMed ID: 33155691
[TBL] [Abstract][Full Text] [Related]
56. Fibromyalgia-like symptoms associated with irritable bowel syndrome: A challenging diagnosis of late-onset Pompe disease.
Gesquière-Dando A; Attarian S; Maues De Paula A; Pouget J; Salort-Campana E
Muscle Nerve; 2015 Aug; 52(2):300-4. PubMed ID: 25703594
[TBL] [Abstract][Full Text] [Related]
57. Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy.
Byrne BJ; Fuller DD; Smith BK; Clement N; Coleman K; Cleaver B; Vaught L; Falk DJ; McCall A; Corti M
Ann Transl Med; 2019 Jul; 7(13):290. PubMed ID: 31392202
[TBL] [Abstract][Full Text] [Related]
58. Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD).
De Filippi P; Errichiello E; Toscano A; Mongini T; Moggio M; Ravaglia S; Filosto M; Servidei S; Musumeci O; Giannini F; Piperno A; Siciliano G; Ricci G; Di Muzio A; Rigoldi M; Tonin P; Croce MG; Pegoraro E; Politano L; Maggi L; Telese R; Lerario A; Sancricca C; Vercelli L; Semplicini C; Pasanisi B; Bembi B; Dardis A; Palmieri I; Cereda C; Valente EM; Danesino C
Curr Issues Mol Biol; 2023 Apr; 45(4):2847-2860. PubMed ID: 37185710
[TBL] [Abstract][Full Text] [Related]
59. Bent spine syndrome as the initial symptom of late-onset Pompe disease.
Taisne N; Desnuelle C; Juntas Morales R; Ferrer Monasterio X; Sacconi S; Duval F; Sole G; Flipo RM; Lacour A; Vermersch P; Cardon T
Muscle Nerve; 2017 Jul; 56(1):167-170. PubMed ID: 27862019
[TBL] [Abstract][Full Text] [Related]
60. Successful combined liver/kidney transplantation from a donor with Pompe disease.
Halldorson J; Kazi Z; Mekeel K; Kuo A; Hassanein T; Loomba R; Austin S; Valasek MA; Kishnani P; Hemming AW
Mol Genet Metab; 2015 Aug; 115(4):141-4. PubMed ID: 26031770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
